Comparing the rate of immunotherapy treatment change due to toxicity by sex

Abstract Background Immuno‐oncology therapy (IO) is associated with a variety of treatment‐related toxicities. However, the impact of toxicity on the treatment discontinuation rate between males and females is unknown. We hypothesized that immune‐related adverse events would lead to more frequent tr...

Descripción completa

Detalles Bibliográficos

Autores principales:	Kevin J. Chua, Shane Kronstedt, Alain Kaldany, Arnav Srivastava, Sai Krishnaraya Doppalapudi, Hao Liu, Ahmad A. Tarhini, Margaret Gatti‐Mays, Elizabeth Gaughan, Siwen Hu‐Lieskovan, Raid Aljumaily, Kenneth Nepple, Bryan Schneider, Joshua Sterling, Eric A. Singer
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2024-02-01
Colección:	Cancer Reports
Materias:	cancer drug side effects immunotherapy oncology sex differences
Acceso en línea:	https://doi.org/10.1002/cnr2.1932
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!